ARK EXCHANGE TRADED FUNDS (ARK ETFs) Third Quarter 2020 | Update as of September 30, 2020
ACTIVELY MANAGED ETFs
ARKQ ARK Autonomous Technology & Robotics ETF* Inception: 09/30/2014
ark-funds.com/arkq
As of September 30, 2020 | All holdings are subject to change.
PORTFOLIO COMPOSITION Element
TOP 10 HOLDINGS (%) Exposure
Company
36.2%
TESLA INC
Robotics
22.0%
MATERIALISE NV-ADR
6.8%
3D Printing
20.3%
2U INC
6.5% 5.1%
13.7%
XILINX INC
Space Exploration
4.8%
PROTO LABS INC
Development of Infrastructure
2.6%
DEERE & CO
3.8%
Innovative Materials
0.1%
JD.COM INC-ADR
3.6%
Alternate Energy Sources
0.1%
ALPHABET INC-CL C
3.4%
TRIMBLE INC
3.4%
TOTAL
ARK Next Generation Internet ETF* Inception: 09/30/2014
ark-funds.com/arkw
PORTFOLIO COMPOSITION Element
Inception: 10/31/2014
ark-funds.com/arkg
3.4% 50.9%
Exposure
Company
Weight
Cloud Computing
18.7%
TESLA INC
11.0%
E-Commerce
18.7%
ROKU INC
6.4%
Big Data & Machine Learning
15.3%
SQUARE INC - A
6.2%
Digital Media
14.3%
ZILLOW GROUP INC - C
3.4%
Internet of Things
11.7%
FACEBOOK INC-CLASS A
3.3%
Social Platforms
9.0%
PINTEREST INC- CLASS A
3.0%
Mobile
8.8%
SEA LTD-ADR
2.8%
Blockchain & P2P
3.3%
LENDINGTREE INC
2.7%
2U INC
2.7%
TOTAL
ARK Genomic Revolution ETF
4.0%
TOP 10 HOLDINGS (%)
HUYA INC-ADR
ARKG
10.9%
Energy Storage
BYD CO LTD-UNSPONSORED ADR
ARKW
Weight
Autonomous Vehicles
PORTFOLIO COMPOSITION Element
2.7% 44.3%
TOP 10 HOLDINGS (%) Exposure
Company
Weight
Molecular Diagnostics
23.5%
INVITAE CORP
Beyond DNA
17.0%
CRISPR THERAPEUTICS AG
8.1%
Gene Therapy
13.7%
PACIFIC BIOSCIENCES OF CALIF
5.6%
Instrumentation
12.5%
TWIST BIOSCIENCE CORP
4.7%
Bioinformatics
12.0%
ARCTURUS THERAPEUTICS HOLDIN
4.7%
Targeted Therapeutics
11.4%
COMPUGEN LTD
4.4%
Next Generation Oncology
8.0%
SERES THERAPEUTICS INC
3.7%
IOVANCE BIOTHERAPEUTICS INC
3.5%
TELADOC HEALTH INC
3.3%
Agricultural Biology Stem Cells
1.2% 0.2%
PERSONALIS INC TOTAL
12.0%
3.1% 53.1%
*Effective as of November 4, 2020, the name of the ARK Web x.0 ETF changed to the “ARK Next Generation Internet ETF” and the name of the ARK Industrial Innovation ETF changed to the “ARK Autonomous Technology & Robotics ETF”. For additional information, please see: www.sec.gov/Archives/edgar/data/1579982/000114420419043539/tv528835_497.htm
ARK Invest | 3 E 28th Street, 7th Floor, New York, NY 10016
|
[email protected] | ark-funds.com
1
ARK INNOVATION ETFs – Third Quarter 2020
ACTIVELY MANAGED ETFs
ARKF ARK Fintech Innovation ETF Inception: 02/04/2019
ark-funds.com/arkf
As of September 30, 2020 | All holdings are subject to change.
PORTFOLIO COMPOSITION Element
TOP 10 HOLDINGS (%) Exposure
Company
Transaction Innovations
27%
SQUARE INC - A
Customer Facing Platforms
23%
MERCADOLIBRE INC
4.5%
Frictionless Funding Platforms
17%
ZILLOW GROUP INC - C
4.3%
Risk Transformations
13%
PINTEREST INC- CLASS A
4.2%
Blockchain
10%
TENCENT HOLDINGS LTD-UNS ADR
4.0%
The New Intermediaries
10%
SEA LTD-ADR
4.0%
LENDINGTREE INC
3.9%
INTERCONTINENTAL EXCHANGE IN
3.7%
ARKK
PORTFOLIO COMPOSITION
ARK Innovation ETF
Element
ark-funds.com/arkk
Cloud Computing E-Commerce Molecular Diagnostics Gene Therapy Big Data & Machine Learning Digital Media 3D Printing Internet of Things Beyond DNA Bioinformatics Mobile Instrumentation Energy Storage Targeted Therapeutics Autonomous Vehicles Next Generation Oncology Robotics Social Platforms Development of Infrastructure Space Exploration Blockchain & P2P Stem Cells
ARK Invest | 3 E 28th Street, 7th Floor, New York, NY 10016
12.3%
ADYEN NV
3.7%
ALIBABA GROUP HOLDING-SP ADR
3.6%
TOTAL
Inception: 10/31/2014
Weight
48.3%
TOP 10 HOLDINGS (%) Exposure 10.1% 9.8% 9.4% 7.5% 7.4% 7.3% 7.3% 5.7% 4.8% 4.6% 4.4% 4.2% 3.6% 2.9% 2.2% 1.9% 1.9% 1.5% 1.1% 0.9% 0.7% 0.1%
|
[email protected] | ark-funds.com
Company TESLA INC
Weight 11.0%
INVITAE CORP
8.8%
SQUARE INC - A
6.4%
ROKU INC
5.3%
CRISPR THERAPEUTICS AG
4.9%
PROTO LABS INC
3.5%
ZILLOW GROUP INC - C
3.4%
2U INC
3.1%
LENDINGTREE INC
2.9%
TELADOC HEALTH INC TOTAL
2.9% 52.0%
2
ARK INNOVATION ETFs – Third Quarter 2020
INDEX ETFs
As of September 30, 2020 | All holdings are subject to change.
PRNT
SECTOR WEIGHTS
The 3D Printing ETF
Sector
Inception: 07/19/2016
ark-funds.com/prnt
TOP 10 HOLDINGS (%) Exposure
Company
Information Technology
61.5%
EXONE CO/THE
Industrials
26.2%
MATERIALISE NV-ADR
6.4%
8.4%
SLM SOLUTIONS GROUP AG
6.0%
Materials
2.6%
RENISHAW PLC
5.9%
Consumer Discretionary
0.8%
PROTO LABS INC
5.1%
Not Classified
0.4%
HP INC
4.9%
Consumer Staples
0.1%
STRAUMANN HOLDING AG-REG
4.8%
MGI DIGITAL GRAPHIC TECHNOLO
4.6%
ALTAIR ENGINEERING INC - A
4.4%
Health Care
TRIMBLE INC TOTAL
IZRL ARK Israel Innovative Technology ETF
Weight
SECTOR WEIGHTS Sector
6.6%
4.4% 53.1%
TOP 10 HOLDINGS (%) Exposure
Company
Weight
Information Technology
48.2%
FIVERR INTERNATIONAL LTD
4.1%
Health Care
26.0%
REDHILL BIOPHARMA LTD-SP ADR
3.6%
Inception: 12/05/2017
Communication Services
10.5%
ark-funds.com/izrl
Industrials
PERION NETWORK LTD
3.1%
7.5%
FATTAL HOLDINGS 1998 LTD
3.1%
Consumer Discretionary
7.2%
PLURISTEM THERAPEUTICS INC
2.9%
Not Classified
0.7%
DANEL (ADIR YEOSHUA) LTD
2.9%
NICE LTD - SPON ADR
2.8%
CAMTEK LTD
2.8%
SAPIENS INTERNATIONAL CORP
2.7%
BEZEQ THE ISRAELI TELECOM CO TOTAL
ARK Invest | 3 E 28th Street, 7th Floor, New York, NY 10016
|
[email protected] | ark-funds.com
2.7% 30.6%
3
ARK INNOVATION ETFs – Third Quarter 2020
QUARTERLY COMMENTARY Catherine D. Wood, ARK Chief Investment Officer
During the third quarter, broad-based equity indexes - as
Relative to the S&P 500 Index and the MSCI World Index,
measured by the S&P 500 and MSCI World – continued to
ARK’s five actively managed ETFs outperformed during the
appreciate, hitting all-time highs. Much like other policymakers
third quarter. ARK’s two self-indexed ETFs turned in mixed
around the world, in an effort to prevent a relapse into
performance.
recession, the Fed reinforced that it will err on the side of ease with an asymmetric response to inflation. Specifically, given
The ARK Autonomous Technology and Robotics ETF (ARKQ)
the long period of time that inflation has hovered below its 2%
outperformed the broad-based market indexes. Among
target, the Fed will not react immediately to readings above
the top contributors to performance was Tesla (TSLA). Tesla
2%; yet, if inflation were to rise and then drop back below
surpassed expectations for revenue and earnings during the
the 2% target, it will respond quickly. On the fiscal policy
second quarter, potentially setting it up for inclusion in the
front, Congress remained deadlocked on the next round
S&P 500 index at some point in the future. At Battery Day,
of fiscal policy measures to support the economy, leaving
Tesla presented plans not only to reduce battery costs by 56%,
incremental stimulus measures to the Fed. Because global
but also to increase range by 54% and reduce capital costs
fiscal and monetary policy makers responded with record-
by 69%, enabling the production of an electric vehicle (EV)
breaking measures to “flatten the curve” and slow the spread
with a $25,000 sticker price during the next three years. In
of COVID-19, fears of an extended global recession appears
our view, Tesla is three to four years ahead of the competition
to have dissipated, giving way to early concerns about “how
in the electric vehicle space. In the absence of specific news,
much is too much”. The Treasury yield curve in the US, for
Materialize (MTLS) also contributed positively to performance,
example, steepened during the third quarter, as long-term
particularly after the COVID-19 pandemic highlighted the
yields increased while short-term rates declined.
importance of its software in quick-turn manufacturing solutions and after Desktop Metal’s roadshow stirred investor
Since the bottom of the market during the COVID-19
interest in 3D printing.
crisis, growth stocks - particularly those associated with companies solving problems created by the pandemic - have
Among the top detractors were Stratasys (SSYS) and 2U (TWOU).
outperformed value stocks significantly. This divergence
3D printing company Stratasys disappointed second quarter
could be a function of fears that the economy will relapse
revenue expectations with sales down nearly 30% on a year-
into recession and that “creative destruction” associated
over-year basis. Its new CEO, Yoav Zeif, is focusing Stratasys
with innovation will plague traditional value sectors like
on plastic 3D printing and manufacturing. 2U detracted from
financial services, energy, and industrials. That said, cyclical
performance even though colleges are adapting to COVID-19
sectors could benefit as producers continue to catch up
by embracing remote education at an accelerated rate. During
with consumer demand during this expansion. The consumer
the second quarter, 2U exceeded top line expectations but
saving rate in the US has dropped from a record high of 34%
missed them on the bottom line and raised roughly $300
during the early days of the pandemic but still is nearly twice
million in a secondary equity offering.
as high as the 8% recorded in March, likely mirroring high rates in the rest of the world and suggesting that pent-up demand
The ARK Next Generation Internet ETF (ARKW) outperformed
will support the recovery now under way. Indeed, given the
the broad-based market indexes during the quarter. Among
record-breaking drawdown in inventories in the US during
the top contributors was Tesla (TSLA) for reasons noted above.
the second and third quarters, businesses seem to have been
Square (SQ) also contributed as its seller businesses recovered
caught off guard and are scrambling to catch up with demand,
much more quickly than expected from the COVID-19 crisis,
suggesting a much stronger than expected V-shaped recovery
and Cash App also delivered stronger than expected growth
during the next year.
during the second quarter. Square pivoted its offline sellers to online commerce, increasing the latter’s gross payment
ARK Invest | 3 E 28th Street, 7th Floor, New York, NY 10016
|
[email protected] | ark-funds.com
4
ARK INNOVATION ETFs – Third Quarter 2020
volume (GPV) by 50%. Roughly one third of its online sellers
top contributors were Square (SQ), for reasons noted above,
were new to Square.
and Zillow (Z). Zillow contributed to performance after a St. Louis Federal Reserve report that homeownership in the
Among the Next Generation Internet’s top detractors were
second quarter rose to levels not seen since July 2009. We
Alteryx (AYX) and Slack Technologies (WORK). Alteryx
believe that the residential real estate market and Zillow will
delivered weak second quarter earnings as revenue growth
continue to benefit from mortgage rates that have dropped to
dropped from 43% on a year over year basis in the first quarter
50-year lows and from the premium now placed on personal
to 17% in the face of flat bookings, triggering our exit. Slack
space as a result of COVID-19.
Technologies detracted from performance after billings growth decelerated from 49% in the first quarter to 24% as
Among the top detractors were Slack Technologies (WORK),
its customers laid off users in response to the COVID-19 crisis.
for reasons noted above, and Splunk (SPLK). Splunk
Slack Connect, which allows intercompany communications,
announced weaker than expected third quarter guidance.
saw a user growth of 200% in the quarter, enabling the
Also Sumo Logi, which offers “Splunk-like” functionality in the
company to capture new customers organically.
cloud, announced that it will conduct an initial public offering. We believe that the breadth and depth of Splunk’s products
The ARK Genomic Revolution ETF (ARKG) outperformed the
are difficult to duplicate.
broad-based market indexes. Among the top contributors to performance was Seres Therapeutics (MCRB). Seres
With some of the highest conviction names from the
Therapeutics appreciated after reporting positive top line data
Funds discussed above, the ARK Innovation ETF (ARKK)
from its SER-109 trial which tested a microbiome therapeutic
outperformed the broad-based indexes during the quarter.
for C. difficile. Invitae (NVTA) contributed to performance
Among the top contributors were Tesla and Square, for reasons
after it acquired ArcherDx, a precision oncology company
noted above. Detracting from performance were Illumina and
focused on high-quality, decentralized molecular diagnostics.
Slack Technologies, for reasons noted above.
We believe that once the two companies integrate, Invitae is likely to offer the most accurate, comprehensive, and flexible
ARK’s self-indexed ETFs, The 3D Printing ETF (PRNT) and the
oncology tests in the world. Moreover, its investments in
ARK Israel Innovation Technology ETF (IZRL), appreciated
telemedicine, AI, genetic counseling, world-class germline
during the quarter, with mixed performance. The 3D Printing
variant
clinical
ETF (PRNT) outperformed relative to the broad-based market
workflows should give Invitae an advantage over the
indexes. Materialize (MTLS) was the largest contributor in PRNT,
competition.
for reasons noted above. 3D Systems (DDD) was the largest
interpretation,
pharmacogenomics,
and
detractor from performance after it missed analysts’ estimates Among the top detractors were Illumina (ILMN) and Inovio
for the second quarter and announced a restructuring focused
Pharmaceuticals (INO). Illumina detracted from performance
on Healthcare and Industrial, spearheaded by new CEO, Jeffrey
primarily because the company announced its intention to
Graves. 3D Systems also appointed Jagtar Narula as CFO, who
increase its ownership of GRAIL, an innovative cancer screening
brings experience from Blackbaud, Xerox, and GE.
company, from 15% to 100% for $8 billion. While GRAIL’s methylation-based approach to multi-cancer screening is
The ARK Israel Innovation Technology ETF (IZRL) under-
accurate and cost-effective, we do not believe that it has a
performed the broad-based market indexes for the period.
significant technological or IP advantage over other screening
The largest detractor was Urogen Pharma (URGN), as its Phase
companies like Guardant Health (GH), Exact Sciences (EXAS), etc.
2 trial missed its primary endpoint of improving overactive
Inovio depreciated primarily because the FDA placed a clinical
bladder symptoms. IZRL’s top contributor to performance
hold on the Phase II/III trial of its COVID-19 vaccine, INO-4800.
was Fiverr International (FVRR), the marketplace for freelance
Inovio will respond in October, at which point the agency will
services, which benefited from the shift to online commerce
have 30 days to decide whether or not the trial can proceed.
in the face of the COVID-19 crisis.
The ARK Fintech Innovation ETF (ARKF) outperformed the broad-based market indexes during the quarter. Among the
ARK Invest | 3 E 28th Street, 7th Floor, New York, NY 10016
|
[email protected] | ark-funds.com
5
ARK INNOVATION ETFs – Third Quarter 2020
PERFORMANCE | Q 3 2020
For the period July 1 — September 30, 2020
Active ETFs
Index ETF
Total Return
ARKQ
ARKW
ARKG
ARKF
ARKK
PRNT
IZRL
NAV
21.26%
27.99%
22.19%
25.16%
29.18%
13.03%
4.79%
MKT Price
21.28%
28.00%
22.14%
25.56%
29.01%
13.30%
4.76%
P E R F O R M A N C E I N P E R S P E C T I V E | Q 3 2020 S&P 500 Index (SPX)
8.93%
MSCI World Net Index (M1WO)
7.93%
Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal will fluctuate so that an investor’s shares when redeemed may be worth more or less than the original cost. For most recent month end performance please call 1-800-679-7759 or visit www.ark-funds.com
BIGGEST CONTRIBUTORS/DETRACTORS | Q3 2020 ARKQ
ARKW
ARKG
ARKF
ARKK
PRNT
IZRL
*A basis point (BP) is a unit that is equal to 1/100th of 1%
TOP 5 STOCKS
BPs*
BOTTOM 5 STOCKS
BPs*
TESLA INC
1007
ELBIT SYSTEMS LTD
-17 -36 -70
MATERIALISE NV-ADR
319
FLIR SYSTEMS INC
DEERE & CO
124
AEROVIRONMENT INC
BYD CO LTD-UNSPONSORED ADR
121
2U INC
WORKHORSE GROUP INC
97
STRATASYS LTD
-70 -107
TESLA INC
881
SPOTIFY TECHNOLOGY SA
SQUARE INC - A
401
2U INC
ROKU INC
336
PURE STORAGE INC - CLASS A
-19 -22 -31
ZILLOW GROUP INC - C
221
SLACK TECHNOLOGIES INC- CL A
-44
PINTEREST INC- CLASS A
176
ALTERYX INC - CLASS A
-52
SERES THERAPEUTICS INC
484
INCYTE CORP
INVITAE CORP
440
SYROS PHARMACEUTICALS INC
PACIFIC BIOSCIENCES OF CALIF
422
SCHRODINGER INC
-35 -39 -72
TWIST BIOSCIENCE CORP
227
INOVIO PHARMACEUTICALS INC
-84
CRISPR THERAPEUTICS AG
167
ILLUMINA INC
-95
SQUARE INC - A
595
TRANSUNION
-4 -9 -10 -12
ZILLOW GROUP INC - C
287
GUIDEWIRE SOFTWARE INC
PINTEREST INC- CLASS A
248
PINDUODUO INC-ADR
APPLE INC
163
SPLUNK INC
SEA LTD-ADR
142
SLACK TECHNOLOGIES INC- CL A
-16
TESLA INC
887
PURE STORAGE INC - CLASS A
SQUARE INC - A
387
2U INC
-28 -29
INVITAE CORP
343
STRATASYS LTD
-40
SERES THERAPEUTICS INC
337
SLACK TECHNOLOGIES INC- CL A
-45
ROKU INC
288
ILLUMINA INC
-64
MATERIALISE NV-ADR
291
NUVASIVE INC
RENISHAW PLC
233
AUTODESK INC
EXONE CO/THE
211
KAISER ALUMINUM CORP
-11 -13 -22
SLM SOLUTIONS GROUP AG
210
STRATASYS LTD
STRAUMANN HOLDING AG-REG
88
3D SYSTEMS CORP
FIVERR INTERNATIONAL LTD
227
BATM ADVANCED COMMUNICATIONS STRATASYS LTD
-108 -152 -49 -50
REDHILL BIOPHARMA LTD-SP ADR
137
PERION NETWORK LTD
83
POLYPID LTD
INMODE LTD
80
TEVA PHARMACEUTICAL-SP ADR
-57 -63
FATTAL HOLDINGS 1998 LTD
77
UROGEN PHARMA LTD
-63
The five holdings that contributed the most and the five holdings that contributed the least to the performance of each ARK ETF during the quarter ended September 30, 2020 are shown. The performance shown represents the amount in basis points that each holding contributed to the performance of the ARK ETF during the quarter. Portfolio holdings are subject to change. Please visit www.ark-funds.com for the most current list of holdings for each ARK ETF. ARK Invest | 3 E 28th Street, 7th Floor, New York, NY 10016
|
[email protected] | ark-funds.com
6
ARK INNOVATION ETFs – Third Quarter 2020
PERFORMANCE OVERVIEW | ACTIVELY MANAGED ETFs
For the period ended September 30, 2020
YTD
One Year
Three Years
Five Years
Since Inception
ARKQ NAV
54.16%
80.81%
23.55%
28.24%
20.24%
ARKQ MKT Price
54.52%
81.04%
23.50%
28.40%
20.27%
S&P 500 Index (SPX)
5.57%
15.15%
12.28%
14.15%
11.47%
MSCI World Net Index (M1WO)
1.70%
10.41%
7.74%
10.48%
7.66%
YTD
One Year
Three Years
Five Years
Since Inception
ARKW NAV
88.25%
123.08%
45.63%
43.20%
36.28%
ARKW MKT Price
88.57%
123.14%
45.56%
43.24%
36.30%
S&P 500 Index (SPX)
5.57%
15.15%
12.28%
14.15%
11.47%
MSCI World Net Index (M1WO)
1.70%
10.41%
7.74%
10.48%
7.66%
ARK Autonomous Technology & Robotics ETF
ARK Next Generation Internet ETF
Annualized
Annualized
Annualized
Annualized
(09/30/14) Annualized
(09/30/14) Annualized
YTD
One Year
Three Years
Five Years
Since Inception
ARKG NAV
89.90%
122.11%
37.37%
29.26%
22.92%
ARKG MKT Price
90.07%
122.43%
37.28%
29.35%
22.94%
S&P 500 Index (SPX)
5.57%
15.15%
12.28%
14.15%
11.46%
MSCI World Net Index (M1WO)
1.70%
10.41%
7.74%
10.48%
7.90%
ARK Genomic Revolution ETF
Annualized
Annualized
(10/31/14) Annualized
YTD
One Year
Three Years
Five Years
Since Inception
ARKF NAV
65.00%
86.20%
N/A
N/A
51.87%
ARKF MKT Price
65.34%
86.88%
N/A
N/A
52.14%
S&P 500 Index (SPX)
5.57%
15.15%
N/A
N/A
16.20%
MSCI World Net Index (M1WO)
1.70%
10.41%
N/A
N/A
11.81%
YTD
One Year
Three Years
Five Years
Since Inception
ARKK NAV
83.72%
115.18%
41.39%
39.20%
30.97%
ARKK MKT Price
83.82%
115.30%
41.21%
39.37%
30.98%
S&P 500 Index (SPX)
5.57%
15.15%
12.28%
14.15%
11.46%
MSCI World Net Index (M1WO)
1.70%
10.41%
7.74%
10.48%
7.90%
ARK Fintech Innovation ETF
ARK Innovation ETF
Annualized
Annualized
Annualized
Annualized
(02/04/19)
(10/31/14) Annualized
Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal will fluctuate so that an investor’s shares when redeemed may be worth more or less than the original cost. Returns for less than one year are not annualized. As stated in the ARK ETFs’ current prospectuses, the expense ratio for ARKK. ARKG, ARKQ, and ARKF is 0.75%. The expense ratio for ARKW is 0.76%.
Additional information about fees and expense levels can be found in the ARK ETFs’ prospectuses. Net asset value (“NAV”) returns are based on the dollar value of a single share of an ARK ETF, calculated using the value of the underlying assets of the ARK ETF minus its liabilities, divided by the number of shares outstanding. The NAV is typically calculated at 4:00 pm Eastern time. Market returns are based on the trade price at which shares are bought and sold on the exchange using the last share trade. Market performance does not represent the returns you would receive if you traded shares at other times. Total Return reflects reinvestment of distributions on ex-date for NAV returns and payment date for Market Price returns. The market price of ARK ETF shares may differ significantly from their NAV during periods of market volatility.
ARK Invest | 3 E 28th Street, 7th Floor, New York, NY 10016
|
[email protected] | ark-funds.com
7
ARK INNOVATION ETFs – Third Quarter 2020
PERFORMANCE OVERVIEW | INDEX ETFs
For the period ended September 30, 2020
Three Years
Since Inception
14.85%
-1.83%
5.01%
6.64%
16.69%
-1.78%
5.13%
The Total 3D Printing Index (3DPRNT)
6.08%
15.85%
-1.28%
6.06%
S&P 500 Index (SPX)
5.57%
15.15%
12.28%
13.24%
MSCI World Net Index (M1WO)
1.70%
10.41%
7.74%
10.17%
YTD
One Year
Three Years
Since Inception
IZRL NAV
11.90%
23.71%
N/A
10.18%
IZRL MKT Price
13.01%
24.01%
N/A
10.40%
ARK Israeli Innovation Index (IZRLINVN)
13.93%
26.56%
—
11.18%
S&P 500 Index (SPX)
5.57%
15.15%
—
11.09%
MSCI World Net Index (M1WO)
1.70%
10.41%
—
6.84%
The 3D Printing ETF
YTD
One Year
PRNT NAV
5.83%
PRNT MKT Price
ARK Israel Innovative Technology ETF
Annualized
Annualized
Annualized (07/19/16)
Annualized (12/05/17)
Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal will fluctuate so that an investor’s shares when redeemed may be worth more or less than the original cost. Returns for less than one year are not annualized. As stated in the ARK ETFs’ current prospectuses, the expense ratio for PRNT is 0.66%. The expense ratio for IZRL is 0.49%. Additional information about fees and expense levels can be found in the ARK ETFs’ prospectuses. Net asset value (“NAV”) returns are based on the dollar value of a single share of an ARK ETF, calculated using the value of the underlying assets of the ARK ETF minus its liabilities, divided by the number of shares outstanding. The NAV is typically calculated at 4:00 pm Eastern time. Market returns are based on the trade price at which shares are bought and sold on the exchange using the last share trade. Market performance does not represent the returns you would receive if you traded shares at other times. Total Return reflects reinvestment of distributions on ex-date for NAV returns and payment date for Market Price returns. The market price of ARK ETF shares may differ significantly from their NAV during periods of market volatility.
FOR FURTHER INFORMATION REGARDING ARK INNOVATION ETFs: Please contact our sales partner, Resolute Investment Distributors: 1-800-679-7 759
Investors should carefully consider the investment objectives and risks as well as charges and expenses of an ARK ETF before investing. This and other information are contained in the ARK ETFs’ prospectuses, which may be obtained by visiting www.ark-funds.com. The prospectus should be read carefully before investing. An investment in an ARK ETF is subject to risks and you can lose money on your investment in an ARK ETF. There can be no assurance that the ARK ETFs will achieve their investment objectives. The ARK ETFs’ portfolios are more volatile than broad market averages. The ARK ETFs also have specific risks, which are described below. More detailed information regarding these risks can be found in the ARK ETFs’ prospectuses. The principal risks of investing in the ARK ETFs include: Equity Securities Risk. The value of the equity securities the ARK ETF holds may fall due to general market and economic conditions. Foreign Securities Risk. Investments in the securities of foreign issuers involve risks beyond those associated with investments in U.S. securities. Health Care Sector Risk. The Health Care Sector may be affected by government regulations and government health care programs. Industrials Sector Risk. The industrials sector includes companies engaged in the aerospace and defense industry, electrical engineering, machinery, and professional services. Information Technology Sector Risk. Information technology companies face intense competition, both domestically and internationally, which may have an adverse effect on profit margins. Cryptocurrency Risk. Cryptocurrency (notably, bitcoin), often referred to as ‘‘virtual currency’’ or ‘‘digital currency,’’ operates as a decentralized, peer-to-peer financial exchange and value storage that is used like money. Some of the ARK actively managed Funds may have exposure to bitcoin, a cryptocurrency, indirectly through an investment in the Bitcoin Investment Trust (‘‘GBTC’’), a privately offered, open-end investment vehicle. Cryptocurrency operates without central authority or banks and is not backed by any government. Even indirectly, cryptocurrencies may experience very high volatility and related investment vehicles like GBTC may be affected by such volatility. As a result of holding cryptocurrency, the Fund may also trade at a significant premium to NAV. Cryptocurrency is also not legal tender. Federal, state or foreign governments may restrict the use and exchange of cryptocurrency, and regulation in the U.S. is still developing. Cryptocurrency exchanges may stop operating or permanently shut down due to fraud, technical glitches, hackers or malware. Detailed information regarding the specific risks of the ARK ETFs can be found in the ARK ETFs’ prospectuses.
ARK Invest | 3 E 28th Street, 7th Floor, New York, NY 10016
|
[email protected] | ark-funds.com
8
ARK INNOVATION ETFs – Third Quarter 2020
Risks specific to Index ETFs include Index Tracking Risk. The returns of the ETF may not match the returns of the underlying index that the ETF is designed to track. Israel Risk. Israeli companies may be adversely affected by changes in political climate, government regulation, world events, economic conditions, and exchange rates. The unique characteristics of securities of Israeli companies and the Israel stock market may have a negative impact on the ETF. Detailed information regarding the specific risks of the ARK ETFs can be found in the ARK ETFs’ prospectuses. Additional risks of investing in ARK ETFs include market, management and non-diversification risks, as well as fluctuations in market value NAV. ETF shares may only be redeemed directly with the ETF at NAV by Authorized Participants, in very large creation units. There can be no guarantee that an active trading market for ETF shares will develop or be maintained, or that their listing will continue or remain unchanged. Buying or selling ETF shares on an exchange may require the payment of brokerage commissions and frequent trading may incur brokerage costs that detract significantly from investment returns. The Fund’s exposure to cryptocurrency may change over time and, accordingly, such exposure may not always be represented in the Fund’s portfolio. Many significant aspects of the U.S. federal income tax treatment of investments in bitcoin are uncertain and an investment in bitcoin may produce income that is not treated as qualifying income for purposes of the income test applicable to regulated investment companies, such as the Fund. GBTC is expected to be treated as a grantor trust for U.S. federal income tax purposes, and therefore an investment by the Fund in GBTC will generally be treated as a direct investment in bitcoin for such purposes. See ‘‘Taxes’’ in the Fund’s SAI for more information. Index Descriptions: The ARK Israeli Innovation Index is designed to track the price movements of exchange listed companies that are incorporated and/or domiciled in Israel whose main business operations are causing disruptive innovation in the areas of genomics, health care, biotechnology, industrials, manufacturing, the Internet or information technology. The Total 3D-Printing Index is composed of equity securities and depositary receipts of exchange listed companies from the U.S., non-U.S. developed markets and Taiwan that are engaged in 3D printing related businesses within the following business lines: (i) 3D printing hardware, (ii) computer aided design and 3D printing simulation software, (iii) 3D printing centers, (iv) scanning and measurement, and (v) 3D printing materials. The S&P 500® Index is a widely recognized capitalization-weighted index that measures the performance of the large- capitalization sector of the U.S. stock market. The MSCI World Net Index represents large and mid-cap equity performance across 23 developed markets countries. Returns shown for the MSCI World Net Index are net of foreign withholding taxes applicable to U.S. investors. Securities in the ETF’s portfolio will not match those in any index. The actively managed ETF strategies are benchmark agnostic and corresponding portfolios may have significant non-correlation to any index. Index returns are generally provided as an overall market indicator. You cannot invest directly in an index. Although reinvestment of dividend and interest payments is assumed, no expenses are netted against an index’s returns. Index performance information was furnished by sources deemed reliable and is believed to be accurate, however, no warranty or representation is made as to the accuracy thereof and the information is subject to correction. The Synopsis presents the views of ARK Invest, and information about the ARK ETFs’ holdings that is believed to be accurate, as of the noted date. The views of ARK Invest and the information about the ARK ETFs’ holdings may change, and ARK Invest and the ARK ETFs disclaim any obligation to advise investors of any such changes. Discussions regarding specific holdings are for illustration only and are not intended as recommendations to purchase or sell individual stocks. Percentages shown for each ARK ETF’s Top Ten holdings are based on the ARK ETF’s total investments. Portfolio Composition categories are determined by ARK Invest. Portfolio holdings will change and should not be considered as investment advice or a recommendation to buy, sell or hold any particular security. The securities identified and described do not represent all of the securities purchased, sold or recommended for client accounts. The reader should not assume that an investment in the securities identified was or will be profitable. Please visit www. ark-funds.com for the most current list of holdings for the ARK ETFs. Certain information was obtained from sources that ARK believes to be reliable; however, ARK does not guarantee the accuracy or completeness of any information obtained from any third party. The information herein is general in nature and should not be considered legal or tax advice. An investor should consult an attorney or tax professional regarding the investor’s specific situation. ARK Investment Management LLC is the investment adviser to the ARK ETFs. Foreside Fund Services, LLC, distributor.
ARK Invest | 3 E 28th Street, 7th Floor, New York, NY 10016
|
[email protected] | ark-funds.com
9